https://femifajimi.org/2026/05/13/ich-e6r3-if-e6r2-was-already-effective-why-do-we-need-r3-a-medical-writers-perspective/'Femi Fajimien2026-05-13T16:18:02+00:00ICH E6(R3): If E6(R2) Was Already Effective, Why Do We Need R3?-A Medical Writer’s Perspectiveregulatory medical writing, Femi Fajimi, clinical trials, medical writing, regulatory writing, GCP, ICH E6 R2, protocol writing, medicalwriting, regulatorywriting, clinicaltrials, FemiFajimi, sciencecommunication, Clinical Research, Good Clinical Practice, ICH E6, ICH E6 R3, Decentralised Clinical Trials, Risk Based Monitoring, RBM, RBQM, Participant Centred Trials, Clinical Operations, Regulatory Affairs, Digital Health, Clinical Trial Innovation, Pharmaceutical Industry, CRO